{"id":"W1572793643","doi":"10.1158/1538-7445.am2014-824","title":"Abstract 824: In vivo efficacy of VAL-083 in the treatment of non-small cell lung cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; Delmar (Canada)","funders":"","keywords":"Medicine; Lung cancer; Gefitinib; Cisplatin; Oncology; Internal medicine; Brain metastasis; Clinical trial; Chemotherapy; Cancer; Metastasis; Cancer research; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001852802,0.0003638484,0.0003872455,0.0002131266,0.000149773,0.0002246705,0.0003117857,0.0004245477,0.003872686],"category_scores_gemma":[0.0001010315,0.0001356446,0.0003570545,0.0002086416,0.0001511239,0.0001697097,0.0001009979,0.000787908,0.0008774118],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002395724,"about_ca_system_score_gemma":0.0004799041,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001375285,"about_ca_topic_score_gemma":0.00125248,"domain_scores_codex":[0.9999107,0.00002547867,0.00000665148,0.00001409534,0.00001845937,0.00002456062],"domain_scores_gemma":[0.9999479,0.000009217393,0.000006815426,0.000005459344,0.000007819433,0.00002274664],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00754741,0.002842601,0.0008668676,0.0003112083,0.00007559126,0.0001326635,0.00004263861,0.001083113,0.9688208,0.0001967594,0.002094834,0.01598559],"study_design_scores_gemma":[0.004303016,0.07273779,0.01810116,0.000045163,0.0002086881,0.000702308,0.00009178829,0.004869287,0.8846166,0.0001905969,0.01409734,0.00003637743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9861581,0.004296217,0.0008123794,0.0003000589,0.0001834216,0.0001832887,0.001651746,0.000215775,0.006198957],"genre_scores_gemma":[0.99053,0.001552826,0.0008536409,0.0002162625,0.00003046018,0.0001154412,0.002738301,0.00003705701,0.003926023],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003872686,"threshold_uncertainty_score":0,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05436315843481817,"score_gpt":0.4469286762644234,"score_spread":0.3925655178296052,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}